Related references
Note: Only part of the references are listed.A global perspective on the issue of access to insulin
David Beran et al.
DIABETOLOGIA (2021)
Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology
Amna Saeed et al.
FRONTIERS IN PHARMACOLOGY (2021)
Failing to address access to insulin in its centenary year would be a catastrophic moral failure
David Beran et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology
Amna Saeed et al.
BMJ OPEN (2020)
A perspective on global access to insulin: a descriptive study of the market, trade flows and prices
D. Beran et al.
DIABETIC MEDICINE (2019)
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology
Amna Saeed et al.
PLOS ONE (2019)
Prices, availability and affordability of insulin products: a cross-sectional survey in Shaanxi Province, western China
Zongjie Li et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2019)
Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study
Gautam Satheesh et al.
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2019)
Insulin prices, availability and affordability in 13 low-income and middle-income countries
Margaret Ewen et al.
BMJ GLOBAL HEALTH (2019)
Challenges constraining insulin access in Nepal-a country with no local insulin production
Abhishek Sharma et al.
INTERNATIONAL HEALTH (2018)
Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017
Abdul Basit et al.
BMJ OPEN (2018)
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
Clara K. Chow et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
The Crux of the Medicine Prices' Controversy in Pakistan
Kah S. Lee et al.
FRONTIERS IN PHARMACOLOGY (2017)
Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China
Chenxi Liu et al.
BMC HEALTH SERVICES RESEARCH (2017)
Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis
Haipeng Wang et al.
ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Delivery of Type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru
M. K. Cardenas et al.
DIABETIC MEDICINE (2016)
Constraints and challenges in access to insulin: a global perspective
David Beran et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Challenges constraining access to insulin in the private-sector market of Delhi, India
Abhishek Sharma et al.
BMJ GLOBAL HEALTH (2016)
Evolution of insulin patents and market exclusivities in the USA
Jing Luo et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
NCD Countdown 2025: accountability for the 25 x 25 NCD mortality reduction target
Robert Beaglehole et al.
LANCET (2014)
Non-communicable diseases and injuries in Pakistan: strategic priorities
Tazeen H. Jafar et al.
LANCET (2013)
Embedding non-communicable diseases in the post-2015 development agenda
George Alleyne et al.
LANCET (2013)
Insulin vials vs. insulin cartridges: Further cost considerations
Mohammad G. Al-Sharayri et al.
SAUDI PHARMACEUTICAL JOURNAL (2013)
Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients Behavioral, socioeconomic, and psychosocial factors
Lori Randall et al.
DIABETES CARE (2011)
Looking beyond the issue of access to insulin: What is needed for proper diabetes care in resource poor settings
David Beran et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
A. Cameron et al.
LANCET (2009)
Diabetes care in sub-Saharan Africa
David Beran et al.
LANCET (2006)
Access to care for patients with insulin-requiring diabetes in developing countries - Case studies of Mozambique and Zambia
D Beran et al.
DIABETES CARE (2005)
Share Paper
